OptimizeRx Corporation
OPRX
$16.98
-$0.27-1.57%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.53M | -2.20M | -78.00K | -9.12M | -4.01M |
| Total Depreciation and Amortization | 1.00M | 1.00M | 1.56M | 1.00M | 1.00M |
| Total Amortization of Deferred Charges | 510.00K | 265.00K | 55.00K | 274.00K | 253.00K |
| Total Other Non-Cash Items | 1.49M | 1.56M | 4.40M | 8.47M | 2.90M |
| Change in Net Operating Assets | 30.00K | 3.24M | -5.75M | 1.17M | 633.00K |
| Cash from Operations | 4.56M | 3.86M | 198.00K | 1.79M | 782.00K |
| Capital Expenditure | -10.00K | -27.00K | -17.00K | -18.00K | -45.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -34.00K | -57.00K | -103.00K | -74.00K | -40.00K |
| Cash from Investing | -44.00K | -84.00K | -120.00K | -92.00K | -85.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -4.50M | -500.00K | -2.50M | -500.00K | -500.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -5.00K | -87.00K | -324.00K | -32.00K | -415.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -4.51M | -587.00K | -2.82M | -532.00K | -915.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.00K | 3.19M | -2.75M | 1.17M | -218.00K |